Spire Wealth Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.2K | Hold |
1,441
| – | – | ﹤0.01% | 1654 |
|
|
2025
Q1 | $11.6K | Hold |
1,441
| – | – | ﹤0.01% | 1794 |
|
|
2024
Q4 | $12.9K | Hold |
1,441
| – | – | ﹤0.01% | 1769 |
|
|
2024
Q3 | $10.6K | Hold |
1,441
| – | – | ﹤0.01% | 1612 |
|
|
2024
Q2 | $8.23K | Sell |
1,441
-650
| -31% | -$3.71K | ﹤0.01% | 1696 |
|
|
2024
Q1 | $10.5K | Hold |
2,091
| – | – | ﹤0.01% | 1700 |
|
|
2023
Q4 | $16.7K | Hold |
2,091
| – | – | ﹤0.01% | 1593 |
|
|
2023
Q3 | $16.2K | Buy |
2,091
+650
| +45% | +$5.05K | ﹤0.01% | 1581 |
|
|
2023
Q2 | $13.9K | Hold |
1,441
| – | – | ﹤0.01% | 1711 |
|
|
2023
Q1 | $15.8K | Hold |
1,441
| – | – | ﹤0.01% | 1703 |
|
|
2022
Q4 | $6K | Hold |
1,441
| – | – | ﹤0.01% | 1760 |
|
|
2022
Q3 | $11K | Sell |
1,441
-400
| -22% | -$3.05K | ﹤0.01% | 1525 |
|
|
2022
Q2 | $19K | Hold |
1,841
| – | – | ﹤0.01% | 1682 |
|
|
2022
Q1 | $23K | Sell |
1,841
-20
| -1% | -$250 | ﹤0.01% | 1749 |
|
|
2021
Q4 | $43K | Buy |
1,861
+320
| +21% | +$7.39K | ﹤0.01% | 1796 |
|
|
2021
Q3 | $34K | Hold |
1,541
| – | – | ﹤0.01% | 1632 |
|
|
2021
Q2 | $20K | Buy |
1,541
+236
| +18% | +$3.06K | ﹤0.01% | 1862 |
|
|
2021
Q1 | $17K | Buy |
+1,305
| New | +$17K | ﹤0.01% | 2206 |
|